Inventor · disambiguated record
Kenneth H. Grabstein
Also filed as: GRABSTEIN KENNETH · GRABSTEIN KENNETH H
38 granted patents·5 pending applications·1,074 citations·filing 1986–2023
98Inventor score
Top patents by PatentIndex Score
43 records- 0198US5078996AActivation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factorIMMUNEX CORP·Filed 1986·Granted Jan 7, 1992·233 cites·26 claims
- 0296US7235240B2Antagonists of interleukin-15AMGEN INC·Filed 2005·Granted Jun 26, 2007·22 cites·24 claims
- 0394US9670521B2Amino acid derivativesMEDIMMUNE LTD·Filed 2013·Granted Jun 6, 2017·22 cites·13 claims
- 0494US8568706B2Modified human interferon-beta polypeptidesGRABSTEIN KENNETH H·Filed 2009·Granted Oct 29, 2013·33 cites·12 claims
- 0594US7067132B2Antagonists of interleukin-15IMMUNER CORP·Filed 2002·Granted Jun 27, 2006·56 cites·18 claims
- 0693US7829659B2Methods of modifying polypeptides comprising non-natural amino acidsALLOZYNE INC·Filed 2008·Granted Nov 9, 2010·27 cites·17 claims
- 0789US7632492B2Modified human interferon-β polypeptidesALLOZYNE INC·Filed 2007·Granted Dec 15, 2009·27 cites·7 claims
- 0889US5795966AAntagonists of interleukin-15IMMUNEX CORP·Filed 1995·Granted Aug 18, 1998·56 cites·7 claims
- 0989US5552303ADNA encoding epithelium-derived T-cell factorIMMUNEX CORP·Filed 1993·Granted Sep 3, 1996·90 cites·21 claims
- 1087US11866466B2Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2018·Granted Jan 9, 2024·3 cites·22 claims
- 1187US5574138AEpithelium-derived T-cell factorIMMUNEX CORP·Filed 1995·Granted Nov 12, 1996·61 cites·7 claims
- 1286US7008624B1Antagonists of interleukin-15IMMUNEX CORP·Filed 2000·Granted Mar 7, 2006·8 cites·38 claims
- 1385US6013480AAntagonists of interleukin-15IMMUNEX CORP·Filed 1998·Granted Jan 11, 2000·43 cites·8 claims
- 1483US9732367B2Cell linesMEDIMMUNE LTD·Filed 2013·Granted Aug 15, 2017·3 cites·6 claims
- 1582US5747024AVaccine adjuvant comprising interleukin-15IMMUNEX CORP·Filed 1995·Granted May 5, 1998·71 cites·10 claims
- 1680US6184359B1Antibodies to epithelium-derived T-cell factorIMMUNEX CORP·Filed 1998·Granted Feb 6, 2001·38 cites·22 claims
- 1780US6165466AAntagonists of interleukin-15IMMUNEX CORP·Filed 1998·Granted Dec 26, 2000·31 cites·14 claims
- 1879US5122459AGene encoding biologically active human interleukin 1IMMUNEX CORP·Filed 1989·Granted Jun 16, 1992·37 cites·11 claims
- 1978US6168783B1Antagonists of interleukin-15IMMUNEX CORP·Filed 1998·Granted Jan 2, 2001·29 cites·10 claims
- 2077US10407482B2Amino acid substituted moleculesALLOZYNE INC·Filed 2013·Granted Sep 10, 2019·1 cites·29 claims
- 2176US5707616AMethod for treating or preventing gastrointestinal disease with epithelium-derived T-cell factorIMMUNEX CORP·Filed 1996·Granted Jan 13, 1998·31 cites·5 claims
- 2275US5162111ATreatment of bacterial diseases with granulocyte-macrophage colony stimulating factorGRABSTEIN KENNETH H·Filed 1986·Granted Nov 10, 1992·35 cites·16 claims
- 2374US6177079B1Antagonists of interleukin-15IMMUNEX CORP·Filed 1998·Granted Jan 23, 2001·22 cites·4 claims
- 2474US5985262AMethod of treatment with epithelium derived T-cell factorIMMUNEX CORP·Filed 1997·Granted Nov 16, 1999·28 cites·3 claims
- 2574US2024309058A1Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2023·Application pending·0 cites
- 2673US7625553B2Method of treating cancer by administering an epithelum-derived T-cell factorIMMUNEX CORP·Filed 2007·Granted Dec 1, 2009·1 cites·3 claims
- 2770US5892001AEpithelium-derived T-cell factor antibodiesIMMUNEX CORP·Filed 1996·Granted Apr 6, 1999·24 cites·3 claims
- 2869US7192935B1Polynucleotides encoding epithelium-derived T-cell factor and uses thereofIMMUNEX CORP·Filed 2000·Granted Mar 20, 2007·3 cites·18 claims
- 2966US7763434B2Antagonists of interleukin-15IMMUNEX CORP·Filed 2007·Granted Jul 27, 2010·0 cites·3 claims
- 3065US2008096819A1Amino acid substituted moleculesALLOZYNE INC·Filed 2007·Application pending·0 cites
- 3163US10253345B2Cell linesMEDIMMUNE LTD·Filed 2017·Granted Apr 9, 2019·0 cites·13 claims
- 3263US10214761B2Amino acid derivativesMEDIMMUNE LTD·Filed 2017·Granted Feb 26, 2019·0 cites·16 claims
- 3363US10202447B2Antibody derivativesMEDIMMUNE LTD·Filed 2015·Granted Feb 12, 2019·1 cites·6 claims
- 3457US9981908B2Amino acid derivativesMEDIMMUNE LTD·Filed 2014·Granted May 29, 2018·0 cites·26 claims
- 3557US2008214439A1Amino acid substituted moleculesALLOZYNE INC·Filed 2008·Application pending·0 cites
- 3655US2025195673A1Compositions and methods for selective depletion of target moleculesFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
- 3751US5474769ATreatment of microbial infection by monocyte stimulation with interleukin-7STERLING WINTHROP INC·Filed 1993·Granted Dec 12, 1995·12 cites·16 claims
- 3849US5660824AMuscle trophic factorFiled 1995·Granted Aug 26, 1997·13 cites·21 claims
- 3945US4882282ADNA sequences encoding bovine interleukin-2IMMUNEX CORP·Filed 1986·Granted Nov 21, 1989·6 cites·6 claims
- 4044US10131920B2Nucleic acid moleculesMEDIMMUNE LTD·Filed 2014·Granted Nov 20, 2018·0 cites·17 claims
- 4142US5681557AUse of interleukin-7 to induce monocytes/macrophages cytotoxic activitySTERLING WINTHROP INC·Filed 1995·Granted Oct 28, 1997·5 cites·3 claims
- 4238US2014127209A1Antibody derivativesGRABSTEIN KENNETH·Filed 2013·Application pending·0 cites
- 4333US5006465AProcess for preparing bovine interleukin-2ANDERSON DIRK M·Filed 1989·Granted Apr 9, 1991·2 cites·27 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →